BWAY
BrainsWay Ltd.
NASDAQ · ILHealthcareMedical - Devices
$16.50+4.90%
Price as of Jul 20, 2026
BWAY profitability
BrainsWay Ltd. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 75.5%
- EBITDA margin
- 22.4%
- EBIT margin
- 10.2%
- Net margin
- 15.7%
- Free cash flow margin
- 20.4%
Returns
- Return on equity
- 11.6%
- Return on assets
- 7.5%
- Return on invested capital
- 7.0%
- Asset turnover
- 0.49x
Cash efficiency
- Cash from operations
- $14.2M
- Cash per share
- $1.49
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.